Management of Infertility
Management of Infertility, a new report from AHRQ’s Effective Health Care Program, summarizes the benefits and harms of treatments for unexplained infertility and infertility related to causes such as polycystic ovarian syndrome, endometriosis, tubal factor infertility, and male factor infertility.
The evidence-based practice report findings support strategies for infertility treatment, such as use of the drug Leterozole versus clomiphene. Authors also explored the harms associated with egg and sperm donation, found no correlation between infertility treatment and maternal cancer, and highlighted areas of research needed for patients and clinicians to make the best possible decisions.
The American College of Obstetricians and Gynecologists will use the report to update its clinical practice guidelines on how to treat infertility.
Select to Management of Infertility
Page originally created April 2019